IQVIA Holdings Inc. 0JDM.L Stock
IQVIA Holdings Inc. Price Chart
IQVIA Holdings Inc. 0JDM.L Financial and Trading Overview
IQVIA Holdings Inc. stock price | 233.21 USD |
Previous Close | 214.61 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 247.58 USD |
Volume | 2.28K USD |
Avg. Volume | 2.65K USD |
Market Cap | 426.48M USD |
Beta (5Y Monthly) | 1.392253 |
PE Ratio (TTM) | 0.3864174 |
EPS (TTM) | 5.54 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0JDM.L Valuation Measures
Enterprise Value | 51.81B USD |
Trailing P/E | 0.3864174 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.02942435 |
Price/Book (mrq) | 6.6908283 |
Enterprise Value/Revenue | 3.575 |
Enterprise Value/EBITDA | 20.278 |
Trading Information
IQVIA Holdings Inc. Stock Price History
Beta (5Y Monthly) | 1.392253 |
52-Week Change | 9.80% |
S&P500 52-Week Change | 20.43% |
52 Week High | 247.58 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 197.57 USD |
200-Day Moving Average | 207.39 USD |
0JDM.L Share Statistics
Avg. Volume (3 month) | 2.65K USD |
Avg. Daily Volume (10-Days) | 1.09K USD |
Shares Outstanding | 202.31M |
Float | 184.04M |
Short Ratio | N/A |
% Held by Insiders | 0.88% |
% Held by Institutions | 90.11% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 7.27% |
Operating Margin (ttm) | 12.73% |
Gross Margin | 34.75% |
EBITDA Margin | 17.62% |
Management Effectiveness
Return on Assets (ttm) | 4.55% |
Return on Equity (ttm) | 17.80% |
Income Statement
Revenue (ttm) | 14.49B USD |
Revenue Per Share (ttm) | 77.7 USD |
Quarterly Revenue Growth (yoy) | 2.39% |
Gross Profit (ttm) | 5.03B USD |
EBITDA | 2.56B USD |
Net Income Avi to Common (ttm) | 1.06B USD |
Diluted EPS (ttm) | 5.537 |
Quarterly Earnings Growth (yoy) | -11.099% |
Balance Sheet
Total Cash (mrq) | 1.6B USD |
Total Cash Per Share (mrq) | 8.61 USD |
Total Debt (mrq) | 13.59B USD |
Total Debt/Equity (mrq) | 229.06 USD |
Current Ratio (mrq) | 0.8 |
Book Value Per Share (mrq) | 31.978 |
Cash Flow Statement
Operating Cash Flow (ttm) | 2.17B USD |
Levered Free Cash Flow (ttm) | 1.22B USD |
Profile of IQVIA Holdings Inc.
Country | United Kingdom |
State | NC |
City | Durham |
Address | 2400 Ellis Road |
ZIP | 27703 |
Phone | 919 998 2000 |
Website | https://www.iqvia.com |
Industry | |
Sector(s) | |
Full Time Employees | 87000 |
IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and decentralized clinical trials, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was incorporated in 2016 and is headquartered in Durham, North Carolina.
Q&A For IQVIA Holdings Inc. Stock
What is a current 0JDM.L stock price?
IQVIA Holdings Inc. 0JDM.L stock price today per share is 233.21 USD.
How to purchase IQVIA Holdings Inc. stock?
You can buy 0JDM.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for IQVIA Holdings Inc.?
The stock symbol or ticker of IQVIA Holdings Inc. is 0JDM.L.
How many shares does IQVIA Holdings Inc. have in circulation?
The max supply of IQVIA Holdings Inc. shares is 1.99M.
What is IQVIA Holdings Inc. Price to Earnings Ratio (PE Ratio)?
IQVIA Holdings Inc. PE Ratio is 0.42118478 now.
What was IQVIA Holdings Inc. earnings per share over the trailing 12 months (TTM)?
IQVIA Holdings Inc. EPS is 5.54 USD over the trailing 12 months.